CNBX Pharmaceuticals Inc. financial data

Symbol
CNBX on OTC
Industry
Pharmaceutical Preparations
Location
#3 Bethesda Metro Center, Suite 700, Bethesda, MD
State of incorporation
NV
Fiscal year end
August 31
Former names
Cannabics Pharmaceuticals Inc. (to 3/16/2022), American Mining Corp (to 5/1/2014), Thrust Energy Corp. (to 5/10/2011)
Latest financial report
10-K - Q3 2024 - Nov 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 4.24 % -44.9%
Return On Equity 29.6 % -84.2%
Return On Assets -420 % +36.9%
Operating Margin -448 % -97.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31.1M shares 0%
Common Stock, Shares, Outstanding 31.1M shares +37.6%
Entity Public Float 438K USD -75.8%
Common Stock, Value, Issued 3.11K USD +37.6%
Weighted Average Number of Shares Outstanding, Basic 30.2M shares +243%
Weighted Average Number of Shares Outstanding, Diluted 30.2M shares +243%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 130K USD -68.3%
Cost of Revenue 6.22K USD
Research and Development Expense 195K USD -54.9%
General and Administrative Expense 518K USD -43%
Operating Income (Loss) -583K USD +37.4%
Net Income (Loss) Attributable to Parent -695K USD +81.3%
Earnings Per Share, Basic -0.02 USD/shares +95.2%
Earnings Per Share, Diluted -0.02 USD/shares +95.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.4K USD -79.6%
Assets, Current 31.4K USD -86%
Property, Plant and Equipment, Net 0 USD -100%
Assets 31.4K USD -93.7%
Liabilities, Current 2.51M USD -0.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -25M USD -2.87%
Stockholders' Equity Attributable to Parent -2.48M USD -22.9%
Liabilities and Equity 31.4K USD -93.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -71.8K USD +25.1%
Net Cash Provided by (Used in) Financing Activities 25K USD
Net Cash Provided by (Used in) Investing Activities -1.2K USD
Common Stock, Shares Authorized 900M shares 0%
Common Stock, Shares, Issued 31.1M shares +37.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.4K USD -79.6%
Deferred Tax Assets, Valuation Allowance 3.47M USD +3.86%
Depreciation 39.5K USD -8.62%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -695K USD +81.3%
Deferred Tax Assets, Operating Loss Carryforwards 3.47M USD +3.86%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 22.5M USD +1.04%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%